KoBioLabs Inc
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.
KoBioLabs Inc (348150) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.000x
Based on the latest financial reports, KoBioLabs Inc (348150) has a cash flow conversion efficiency ratio of 0.000x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩23.39 Million) by net assets (₩49.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
KoBioLabs Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how KoBioLabs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
KoBioLabs Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of KoBioLabs Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gunnison Copper Corp
OTCQB:GCUMF
|
0.091x |
|
GBM Resources Ltd
AU:GBZ
|
-0.012x |
|
Mega Or
TA:MGOR
|
0.015x |
|
ZOO BERLIN N M AQ
BE:ZOO
|
N/A |
|
Taeyang Metal
KO:004100
|
0.052x |
|
Invictus Energy Ltd
AU:IVZ
|
-0.015x |
|
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
|
0.008x |
|
Globex Mining Enterprises Inc
OTCQX:GLBXF
|
-0.028x |
Annual Cash Flow Conversion Efficiency for KoBioLabs Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of KoBioLabs Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩37.92 Billion | ₩-4.36 Billion | -0.115x | +48.67% |
| 2023-12-31 | ₩61.82 Billion | ₩-13.83 Billion | -0.224x | -4.50% |
| 2022-12-31 | ₩77.32 Billion | ₩-16.56 Billion | -0.214x | -55.41% |
| 2021-12-31 | ₩90.59 Billion | ₩-12.48 Billion | -0.138x | +40.24% |
| 2020-12-31 | ₩55.39 Billion | ₩-12.77 Billion | -0.231x | -316.56% |
| 2019-12-31 | ₩-53.62 Billion | ₩-5.71 Billion | 0.106x | -36.24% |
| 2018-12-31 | ₩-11.88 Billion | ₩-1.98 Billion | 0.167x | -- |